CLEC12A
From Wikipedia, the free encyclopedia
|
C-type lectin domain family 12, member A
|
||||||||
| Identifiers | ||||||||
| Symbol(s) | CLEC12A; CLL1; CLL-1; DCAL-2; MGC70602; MICL | |||||||
| External IDs | MGI: 3040968 HomoloGene: 51378 | |||||||
|
||||||||
| Orthologs | ||||||||
| Human | Mouse | |||||||
| Entrez | 160364 | 232413 | ||||||
| Ensembl | ENSG00000172322 | ENSMUSG00000053063 | ||||||
| Refseq | NM_138337 (mRNA) NP_612210 (protein) |
NM_177686 (mRNA) NP_808354 (protein) |
||||||
| Location | Chr 12: 10.02 - 10.03 Mb | Chr 6: 129.32 - 129.33 Mb | ||||||
| Pubmed search | [1] | [2] | ||||||
C-type lectin domain family 12, member A, also known as CLEC12A, is a human gene.[1]
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. The protein encoded by this gene is a negative regulator of granulocyte and monocyte function. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. This gene is closely linked to other CTL/CTLD superfamily members in the natural killer gene complex region on chromosome 12p13.[1]
[edit] References
[edit] Further reading
- Drickamer K (1999). "C-type lectin-like domains.". Curr. Opin. Struct. Biol. 9 (5): 585–90. PMID 10508765.
- van Rhenen A, van Dongen GA, Kelder A, et al. (2007). "The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.". Blood 110 (7): 2659–66. doi:. PMID 17609428.
- Marshall AS, Willment JA, Pyz E, et al. (2006). "Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation.". Eur. J. Immunol. 36 (8): 2159–69. doi:. PMID 16838277.
- Chen CH, Floyd H, Olson NE, et al. (2006). "Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production.". Blood 107 (4): 1459–67. doi:. PMID 16239426.
- Bakker AB, van den Oudenrijn S, Bakker AQ, et al. (2005). "C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.". Cancer Res. 64 (22): 8443–50. doi:. PMID 15548716.
- Han Y, Zhang M, Li N, et al. (2004). "KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity.". Blood 104 (9): 2858–66. doi:. PMID 15238421.
- Marshall AS, Willment JA, Lin HH, et al. (2004). "Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes.". J. Biol. Chem. 279 (15): 14792–802. doi:. PMID 14739280.
- Ebner S, Sharon N, Ben-Tal N (2003). "Evolutionary analysis reveals collective properties and specificity in the C-type lectin and lectin-like domain superfamily.". Proteins 53 (1): 44–55. doi:. PMID 12945048.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.

